- Home
- AMWL vs CHRS Comparison
AMWL vs CHRS Comparison
Compare AMWL & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- CHRS
- Stock Information
- Founded
- AMWL 2006
- CHRS 2010
- Country
- AMWL United States
- CHRS United States
- Employees
- AMWL N/A
- CHRS N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMWL Technology
- CHRS Health Care
- Exchange
- AMWL Nasdaq
- CHRS Nasdaq
- Market Cap
- AMWL 121.9M
- CHRS 94.0M
- IPO Year
- AMWL 2020
- CHRS 2014
- Fundamental
- Price
- AMWL $7.15
- CHRS $0.81
- Analyst Decision
- AMWL Hold
- CHRS Strong Buy
- Analyst Count
- AMWL 6
- CHRS 4
- Target Price
- AMWL $11.90
- CHRS $5.38
- AVG Volume (30 Days)
- AMWL 45.2K
- CHRS 2.1M
- Earning Date
- AMWL 04-30-2025
- CHRS 05-08-2025
- Dividend Yield
- AMWL N/A
- CHRS N/A
- EPS Growth
- AMWL N/A
- CHRS N/A
- EPS
- AMWL N/A
- CHRS 0.25
- Revenue
- AMWL $254,364,000.00
- CHRS $266,959,999.00
- Revenue This Year
- AMWL $2.28
- CHRS N/A
- Revenue Next Year
- AMWL $10.06
- CHRS $9.02
- P/E Ratio
- AMWL N/A
- CHRS $3.24
- Revenue Growth
- AMWL N/A
- CHRS 3.78
- 52 Week Low
- AMWL $5.00
- CHRS $0.66
- 52 Week High
- AMWL $17.18
- CHRS $2.61
- Technical
- Relative Strength Index (RSI)
- AMWL 29.97
- CHRS 33.61
- Support Level
- AMWL $7.62
- CHRS $0.89
- Resistance Level
- AMWL $8.24
- CHRS $1.07
- Average True Range (ATR)
- AMWL 0.34
- CHRS 0.08
- MACD
- AMWL 0.03
- CHRS -0.01
- Stochastic Oscillator
- AMWL 4.96
- CHRS 6.10
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.